BusinessTesaro Announces Opening of Niraparib Expanded Access Program for U.S. Patients With Ovarian CancerBy Nasdaq OMXJan 17, 2017, 1:03 PM UTC
BusinessAptevo Therapeutics Receives $20 Million Payment From Emergent BioSolutionsBy Nasdaq OMXJan 13, 2017, 2:02 PM UTC
BusinessKraig Biocraft Laboratories’ Management Completes Meetings with Vietnamese OfficialsBy Nasdaq OMXJan 12, 2017, 11:05 AM UTC
BusinessCytoDyn Files for Breakthrough Therapy Designation With the FDA for PRO 140 in HIV TherapyBy Nasdaq OMXJan 11, 2017, 11:30 AM UTC
BusinessAXIM Biotech Attends Biotech Showcase and J.P. Morgan Healthcare Conferences in San FranciscoBy Nasdaq OMXJan 10, 2017, 2:01 PM UTC
BusinessAllergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development ProgramsBy Nasdaq OMXJan 9, 2017, 1:02 PM UTC
BusinessAllergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development ProgramsBy Nasdaq OMXJan 9, 2017, 1:02 PM UTC
BusinessXeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEOBy Nasdaq OMXJan 9, 2017, 12:00 PM UTC
